GlassScriptPhysician profile
Paul A Fedalen
NPI 1538151741
$4,363.42
in general payments reported to CMS, 2019-2025
21 companies · $133 in 2025
The $133 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $223 · 2021: $1,840 · 2022: $832 · 2023: $13.41 · 2024: $1,174 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677 · Travel and Lodging: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.19 |
| Travel and Lodging | $643.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,221.77 | 2021 | |
| Ethicon US, LLC | $665.58 | 2019-2024 | Harmonic |
| Medtronic, INC. | $646.95 | 2021-2023 | Endurant Iis |
| Zimmer Biomet Holdings, INC. | $643.20 | 2024 | Ribfix Blu Advantage, Advantagerib |
| Olympus Corporation of The Americas | $324.78 | 2022 | |
| 4web, INC. | $144.00 | 2024 | Spine Truss System |
| Silk Road Medical, INC. | $134.97 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Davol INC. | $116.81 | 2022 | |
| Becton, Dickinson and Company | $66.87 | 2019-2022 | |
| Stryker Corporation | $63.17 | 2025 | Na |
| Smith+Nephew, INC. | $61.94 | 2024 | Intellio Link Werewolf |
| Atricure, INC. | $54.83 | 2019-2025 | Atriclip Laa Exclusion System |
| Boston Scientific Corporation | $47.63 | 2025 | Enroute Transcarotid Stent |
| Ambu INC. | $36.33 | 2024 | |
| Acacia Pharma INC | $27.30 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $25.32 | 2021 | |
| Baxter Healthcare | $22.42 | 2019 | |
| Kls-Martin L.P. | $15.87 | 2024 | |
| Mallinckrodt Enterprises LLC | $15.19 | 2019 | |
| Angiodynamics, INC. | $15.08 | 2021 | |
| Medtronic Vascular, INC. | $13.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Fedalen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.